TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, announces the nomination of Steve Swinson as new Chairman of the Board of Directors. “Vexim and the Board of Directors are proud to welcome Steve Swinson as Chairman of the Board of Vexim. […]
NEWS
Vexim Announces the Nomination of Steve Swinson as New Chairman of the Board of Directors
TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, announces the nomination of Steve Swinson as new Chairman of the Board of Directors. “Vexim and the Board of Directors are proud to welcome Steve Swinson as Chairman of the Board of Vexim. Steve […]
Thank you very much to A-Spine as GOLD Sponsor 2016 to SPINEMarketNews.com
Thank you very much to A-Spine for their GOLD sponsorship 2016 to SPINEMarketNews.com. Founded in June 2001 and based in Taipei, A-Spine Asia (ASA) is an emerging medical device company dedicated to the research, development, manufacturing and marketing of spinal implants and instruments for better spine health management. In addition to its leading position in […]
RMIT and Anatomics join forces to produce Australia’s first 3D printed spine implant
Researchers at RMIT University have joined forces with medical device specialist Anatomics to produce a 3D printed vertebral cage for a patient with severe back pain. The medical device is Australia’s first 3D printed spine implant. Read more »
RMIT and Anatomics join forces to produce Australia’s first 3D printed spine implant
Researchers at RMIT University have joined forces with medical device specialist Anatomics to produce a 3D printed vertebral cage for a patient with severe back pain. The medical device is Australia’s first 3D printed spine implant. Read more »
Novartis’ Cosentyx® show no progression in spinal damage in 80% of ankylosing spondylitis patients
Basel, November 23, 2015 – Novartis announced today that the European Commission (EC) has approved Cosentyx(R) (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor […]
Novartis’ Cosentyx® show no progression in spinal damage in 80% of ankylosing spondylitis patients
Basel, November 23, 2015 – Novartis announced today that the European Commission (EC) has approved Cosentyx(R) (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) […]
New Medical Device Company Launches with Spinal Implants and Biologics
SAN ANTONIO, TX (PRWEB) NOVEMBER 18, 2015–Nvision, a medical device and biologics developer and manufacturer focused on spinal implants, announces its launch with four initial proprietary products for distribution. Nvision will provide products that combine implants, instrumentation, biologics and high-touch customer service to deliver a complete solution for surgeons, facilities and distributors. Nvision is committed to […]
New Medical Device Company Launches with Spinal Implants and Biologics
SAN ANTONIO, TX (PRWEB) NOVEMBER 18, 2015–Nvision, a medical device and biologics developer and manufacturer focused on spinal implants, announces its launch with four initial proprietary products for distribution. Nvision will provide products that combine implants, instrumentation, biologics and high-touch customer service to deliver a complete solution for surgeons, facilities and distributors. Nvision is committed […]
LDR Announces Coverage Policy Recommendation Update From NASS to Include Both One and Two-Level Cervical Disc Replacement
AUSTIN, Texas, Nov. 17, 2015 (GLOBE NEWSWIRE) — LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that the North American Spine Society (NASS) has revised its formal coverage recommendation for Cervical Artificial Disc […]
Zyga Technology Completes $20 Million Financing
MINNETONKA, Minn., Nov. 17, 2015 /PRNewswire/ — Zyga Technology, Inc., a medical device company focused on the design, development, and commercialization of minimally invasive devices to treat underserved conditions of the lumbar spine, today announced that it has completed a $20 million round of financing. The company intends to use the proceeds to support growing […]
Nexxt Spine Announces Launch of the DT Elite Guide System
NOBLESVILLE, Ind.–(BUSINESS WIRE)–Nexxt Spine, LLC, founded in 2009, a privately held medical device company dedicated to increasing procedural efficiency and patient outcomes through development of innovative products, manufactured on the most technologically advanced platforms, and utilizing irreproachable quality standards to treat painful and debilitating spinal pathologies, today announced the launch of the DT Elite Guide […]
Salvaged From Bankruptcy, TranS1 Medical Device Finds New Life
Spinal fusion is a complex procedure that requires a surgeon to navigate through muscle, nerves, and organs before reaching bone. TranS1, a Raleigh, NC, medical device company, developed an alternative: a minimally invasive medical de ice that can fuse the lowest spinal joint in less time, at less cost, and with faster patient recovery. Read […]
We are pleased to announce the launch of our NEW Website!
SPINEMarketGroup is pleased to announce the release of a NEW Website, designed with a new look and updated with the latest information about the Spinal Market. Since 2009 our aim has been to inform the Spine Industry professionals about products launches, companies, acquisitions, FDA approvals and more issues related this industry.Throughout the process of developing our […]
Amedica Corporation Reports Third Quarter 2015 Financial Results
SALT LAKE CITY, Nov. 12, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride ceramics as a platform for biomedical applications, today announced financial results for the third quarter ended September 30, 2015. Recent Company Highlights Cash and cash equivalents totaled $11.3 million, and net cash used […]
Orthozon Names GM Medical Master Distributor for LUMIERE System in Asia-Pacific
STAMFORD, CT–(Marketwired – November 11, 2015) – ORTHOZON Technologies Inc. (“ORTHOZON” or the “Company”), developers and providers of minimally invasive access technologies for spine surgery, today announced the signing of a distribution agreement appointing GM Medical Pacific Limited (“GM Medical”) the exclusive distributor of the Company’s LUMIERE Minimally Invasive Access System (“LUMIERE” or “LUMIERE System”) […]
VertiFlex®, Inc. Announces Two Significant Reimbursement Milestones to Expand Market Opportunity for Superion® Interspinous Spacer
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–VertiFlex®, Inc., a leading innovator of advanced minimally invasive interventions for spinal stenosis, announced today that the AMA CPT® Editorial Panel has approved the addition of Category I CPT codes to describe one and two level insertion of interspinous spacers at their October 2015 meeting. The new Category I codes will replace […]
Economic Analysis Demonstrates Substantial Spine Surgery Cost Savings with TranS1 AxiaLIF
DENVER–(BUSINESS WIRE)–The AxiaLIF procedure from TranS1®, a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine, provides an estimated savings of $3,500 when compared to the Transformational Lumbar Interbody Fusion (TLIF) surgery option according to a recent study. Axial Lumbar Interbody Fusion (AxiaLIF) is designed to create […]
Amedica Submits 24-Month Clinical Data to FDA for Clearance of Composite Interbody Spinal Device
SALT LAKE CITY, Nov. 10, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce that it has submitted to the FDA the 24-month clinical data outcomes from its CASCADE study, a blinded, randomized clinical trial that compared outcomes of cervical […]
Interventional Spine Gains FDA Clearance of Advanced Design of Its Expandable Opticage® for Spinal Fusion
IRVINE, Calif., Nov. 10, 2015 /PRNewswire/ — Interventional Spine, Inc. today announced the FDA clearance of their next generation Opticage® Expandable Interbody Fusion Device. The next generation system is an enhanced version of the original Opticage® system that was introduced in 2012. This next generation Opticage® system continues to provide all of the beneficial features […]
Invibio Biomaterial Solutions’ New High-Performance Biocompatible Polymer, PEEK-OPTIMA® HA Enhanced, Soon to be Available in China for Spinal Fusion Implants
THORNTON CLEVELEYS (UK) (PRWEB) NOVEMBER 09, 2015–An innovative high-performance polymer for spinal fusion implants, PEEK-OPTIMA® HA Enhanced, which enables early and direct bone apposition, has now passed biocompatibility testing in China.1 This paves the way for approval by the China Food and Drug Administration (CFDA) and local legal compliance, as confirmed in the Regulatory Affairs […]
Alphatec Holdings Announces Third Quarter 2015 Revenue and Financial Results
CARLSBAD, Calif., Nov, 2015 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced last week financial results for the third quarter ended September 30, 2015. “Q3 marks a turning point for Alphatec where we are beginning to see early results from our […]
Comments about the role of the Industry in the Surgeons Education. Which is the Future of Scientific Support with very low prices?
November 6, 2015–“A value chain is a set of activities that a firm operating in a specific industry performs in order to deliver a valuable product or service for the market”. In the Spinal Industry, after the Company market an implant, the organization carries out a set of activitiest that create value for its customers […]
Amedica Corporation Signs Additional Silicon Nitride Private Label Agreement
SALT LAKE CITY, Nov. 05, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce it has entered into a multi-year private label agreement with a regional medical device company that markets solutions for the treatment of spinal disorders. Pursuant to […]
VEXIM’s Excellent Performance Ranked in Technology Fast 50 for Southwestern France by Deloitte In Extenso
TOULOUSE, France–VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, announces that the company has received the Award of the fastest growing listed company, and was ranked 4th in the 2015 Technology Fast 50 for southwestern France by Deloitte in Extenso. The ceremony took place on […]
VEXIM’s Excellent Performance Ranked in Technology Fast 50 for Southwestern France by Deloitte In Extenso
TOULOUSE, France–VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, announces that the company has received the Award of the fastest growing listed company, and was ranked 4th in the 2015 Technology Fast 50 for southwestern France by Deloitte in Extenso. The ceremony took place on […]
Cerapedics Receives FDA Approval for i-FACTOR™ Peptide Enhanced Bone Graft in Cervical Spine Surgery
WESTMINSTER, Colo., Nov. 3, 2015 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved the company’s Premarket Approval (PMA) application for i-FACTOR™ Peptide Enhanced Bone Graft for use in anterior cervical discectomy and fusion (ACDF) procedures in patients with degenerative cervical disc disease. i-FACTOR bone graft […]